Organisation paid for research Program year 2022 Source: CMS Open Payments

Univ Retina + MacUla

Neither a doctor nor a teaching hospital

Research payments

$866,243

36 payments

Through program year 2022, Univ Retina + MacUla is reported as receiving $866,243 in research payments, across 36 payments.

By program year

1 row

Year	Kind	Amount	Payments
2022	Research	$866,243	36

Breakdown

Who paid Research payments · program year 2022

Genentech, Inc. $866,243 36 payments

Studies the money was for Research payments · program year 2022

Faricimab Dme Long Term Extension Rhone X $374,422 5 payments
Open Label Extension Study to Evaluate the Long Term Safety of Faricimab in Patients With Namd $140,427 6 payments
Study of the Port Delivery System With Ranibizumab in Patients With Diabetic MacUlar Edema $121,398 4 payments
A Phase III Study to Evaluate Faricimab in Patients With Branch Retinal Vein Occlusion $98,929 4 payments
Va2 Phiii $47,321 3 payments
Preclinical05032022 $35,482 4 payments
A Phase III Study to Evaluate Faricimab in Patients With Central Retinal Vein Occlusion $34,688 5 payments
Port Delivery System of Ranibizumab Extension Study $12,843 4 payments
Va2 Phiii Rhine $732 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.